Form 10 Explorer
10-Q
Quarterly Report
ACRO BIOMEDICAL CO., LTD.

CIK: 1622996

File #: 000-55643

Period End: Jun 30, 2024

Fiscal Year: 2024

View on EDGAR
Balance Sheet
28 line items · 2 periods
XBRL
ItemJun 30, 2024Dec 31, 2023
Balance Sheets
ASSETS
Current Assets
Cash
926376
Other Non-Operating Current Assets
01,250
Total Current Assets
9261,626
Operating Lease Right-of-Use Asset
39,75552,233
Other Non-Operating Current Assets
4,6004,600
TOTAL ASSETS
45,28158,459
Current Liabilities
Accounts Payable
152,736154,444
Other Current Liabilities
20,00020,000
Due to related parties
109,18888,796
CEO
1,1001,100
Operating Lease Liability, Current
26,10525,335
Total Current Liabilities
308,029288,575
Operating Lease Liability, Non-Current
13,65026,898
TOTAL LIABILITIES
321,679315,473
Preferred Stock
00
Total Stockholders' Equity
60,04260,042
Total Stockholders' Equity
32,300,45332,298,442
Total Stockholders' Equity
(32,636,893)(32,615,498)
Total Stockholders' Deficit
(276,398)(257,014)
Accumulated Deficit
(32,636,893)(32,615,498)
Additional Paid-In Capital
32,300,45332,298,442
Preferred Stock
00
Common Stock
60,04260,042
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT
45,28158,459